文献速递血栓与止血贫血与红细胞疾病

140214名英国生物银行参与者中遗传性止血障碍致病及可能致病变异的影响

The effects of pathogenic and likely pathogenic variants for inherited hemostasis disorders in 140 214 UK Biobank participants.
PubMed 文献 · Blood · 2023-01-01

研究分析140214名无亲缘关系的英国生物银行参与者,每人中位携带7个既往报告为致病或可能致病的变异;聚焦12367名参与者中967个罕见出血、血栓及血小板疾病诊断级基因变异,通过关联分析估计部分变异对血小板计数和体积的效应量及出血和血栓的比值比。

要点

  • 部分常染色体隐性血小板疾病致病变异在携带者中显示表型后果。
  • MPL功能丧失变异在携带者中意外与血小板计数升高相关。
  • GWAS识别的常见变异可能影响BTPD诊断级基因罕见变异的外显率。

核心结论

  • 利用大型人群数据集进行关联分析可改善罕见变异的致病性分类。

研究设计与样本

  • 研究纳入140214名无亲缘关系的英国生物银行参与者,分析967个罕见出血、血栓及血小板疾病诊断级基因变异,这些变异见于12367名参与者。

主要发现

  • 每名参与者中位携带7个既往报告为致病或可能致病的变异。
  • 对部分变异估计了血小板计数和体积的效应量及出血和血栓的比值比。
  • MPL功能丧失变异在携带者中意外与血小板计数升高相关。
  • GWAS识别的血小板计数或血栓风险常见变异可能影响BTPD诊断级基因罕见变异对相关止血障碍的外显率。
  • 对18410个节点和571917条边的相互作用网络进行网络传播分析显示,效应量大的GWAS变异富集于诊断级基因及其一阶相互作用因子。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rare genetic diseases affect millions, and identifying causal DNA variants is essential for patient care. Therefore, it is imperative to estimate the effect of each independent variant and improve their pathogenicity classification. Our study of 140 214 unrelated UK Biobank (UKB) participants found that each of them carries a median of 7 variants previously reported as pathogenic or likely pathogenic. We focused on 967 diagnostic-grade gene (DGG) variants for rare bleeding, thrombotic, and platelet disorders (BTPDs) observed in 12 367 UKB participants. By association analysis, for a subset of these variants, we estimated effect sizes for platelet count and volume, and odds ratios for bleeding and thrombosis. Variants causal of some autosomal recessive platelet disorders revealed phenotypic consequences in carriers. Loss-of-function variants in MPL, which cause chronic amegakaryocytic thrombocytopenia if biallelic, were unexpectedly associated with increased platelet counts in carriers. We also demonstrated that common variants identified by genome-wide association studies (GWAS) for platelet count or thrombosis risk may influence the penetrance of rare variants in BTPD DGGs on their associated hemostasis disorders. Network-propagation analysis applied to an interactome of 18 410 nodes and 571 917 edges showed that GWAS variants with large effect sizes are enriched in DGGs and their first-order interactors. Finally, we illustrate the modifying effect of polygenic scores for platelet count and thrombosis risk on disease severity in participants carrying rare variants in TUBB1 or PROC and PROS1, respectively. Our findings demonstrate the power of association analyses using large population datasets in improving pathogenicity classifications of rare variants.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Stefanucci L, Collins J, Sims MC, et al. The effects of pathogenic and likely pathogenic variants for inherited hemostasis disorders in 140 214 UK Biobank participants. Blood. 2023. PMID: 37647632. doi:10.1182/blood.2023020118

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。